Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Zoom Stock Dead With Vaccines Rolling Out?


It's no secret that Zoom Video Communications (NASDAQ: ZM) was the stock to own in 2020. The vast majority of face-to-face interactions worldwide were replaced with the company's application in a matter of weeks. Never before has such a company become so important, so quickly.

But after the stock advanced over 750% in the year ending last October, it has stalled. The reason is clear: With vaccines rolling out worldwide, many are wondering if Zoom's technology will remain in such high demand. That can lead many investors -- especially beginning investors -- to ignore the prospects for Zoom's future. 

In this June 14 video from the YouTube channel of Motley Fool contributors Brian Stoffel and Brian Feroldi, you'll see why the long-term story for Zoom could be far rosier than many expect.

Continue reading


Source Fool.com

Like: 0
ZM
Share

Comments